The independent source for health policy research, polling, and news.
641-660 of 1,318 results
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.
A rule finalized this spring by the Trump administration permits employers and insurers not to apply drug company copayment assistance toward enrollees鈥 deductibles and out-of-pocket maximums for any drug.
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN鈥檚 Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
KHN executive editor Damon Darlin wades through mounds of health care policy stories 鈥 so you don鈥檛 have to.
Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one of the largest cash hauls in Congress. And it鈥檚 only her first term.
Trials are an immense undertaking involving tens of thousands of participants. They鈥檙e likely to start this summer 鈥 but don鈥檛 expect quick results. And what鈥檚 a successful result, anyway?
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
KHN鈥檚 Julie Rovner joins a panel of journalists on 鈥1A鈥 to talk about promising results in a study of the drug remdesivir and other developments in the battle against the coronavirus.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act鈥檚 鈥渞isk corridors鈥 provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Carmen Heredia Rodriguez, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 installment about COVID testing that should have been free but was not.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Many Americans order drugs from Canada and other countries because they are cheaper, but U.S. authorities appear to be cracking down on the practice.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it鈥檚 safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation鈥檚 governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies鈥 assistance doesn鈥檛 count toward their members鈥 deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
漏 2026 KFF